COMMUNIQUÉS West-GlobeNewswire

PHARMAGEST: major acquisition in the hospital information systems sector.

20/07/2017 - 18:00

Villers-lès-Nancy, 18 July 2017 - 7:00 p.m. (CET) PRESS RELEASE HOSPITAL INFORMATION SYSTEMS MAJOR ACQUISITION MALTA INFORMATIQUE, a PHARMAGEST Group subsidiary ( Euronext Paris #FR 0012882389 - PHA.PA ), announces the [...]

DarioHealth Announces Strategic Partnership with CCS Medical

24/07/2017 - 14:00

New initiative to provide diabetes patients across the U.S. with access to live monitoring and coaching via CCS Medical's LivingConnected program Caesarea, Israel and Dallas - July 24, 2017 - DarioHealth Corp. (NASDAQ: [...]

Auris Medical Completes Acquisition of AM-125 Assets

20/07/2017 - 14:00

Closing of asset transfer from Otifex Therapeutics Rights to additional preclinical and clinical data complement scope of data package Initiation of Phase 1 trial of AM-125 planned for the fourth quarter of 2017 ZUG, [...]

ProMIS Neurosciences Announces CDN$3 Million Best-Efforts Private Placement

20/07/2017 - 13:30

/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, ON - July 20, 2017 - ProMIS Neurosciences Inc. ("ProMIS" or the "Company") (TSX:PMN; OTCPK:ARFX.F; DB:23J) today [...]

LIDDS: LIDDS and Recipharm establish industrial manufacturing capabilities for a novel prostate cancer product

20/07/2017 - 10:00

LIDDS and Recipharm, the contract development and manufacturing organisation (CDMO), have together set up a manufacturing line for LIDDS' novel prostate cancer drug, Liproca® Depot, at Recipharm in Solna, Sweden. The [...]

Enzymatica AB: Continued sales growth and breakthrough order from STADA

20/07/2017 - 08:00

Enzymatica Interim report Jan-june2017 This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are [...]

Basilea announces completion of the license agreement with Pfizer for antifungal Cresemba® for Europe, Russia, Turkey and Israel

20/07/2017 - 07:15

Basel, Switzerland, July 20, 2017 - Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that its license agreement with Pfizer Inc. (NYSE: PFE) for Basilea's antifungal Cresemba (isavuconazole), which was announced on [...]

ABLYNX AND SANOFI ENTER INTO A STRATEGIC COLLABORATION TO DEVELOP NANOBODY PRODUCT CANDIDATES FOCUSED ON IMMUNE-MEDIATED INFLAMMATORY DISEASES

20/07/2017 - 07:00

REGULATED INFORMATION GHENT, Belgium, 20 July 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced that it has entered into a research collaboration and global exclusive licensing agreement with Sanofi [...]

EDAP to Host Webcast Discussing HIFU Devices with an American Key Opinion Leader

19/07/2017 - 22:15

Webcast to be held Thursday, July 27 th , 2017 LYON, France, July 18, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the Company plans to host an [...]

Diaxonhit : Acquisition de la société de diagnostic médical GENBIO aux Etats-Unis

19/07/2017 - 17:45

DIAXONHIT annonce l'acquisition de la société GENBIO aux Etats-Unis Acquisition stratégique d'une entreprise commerciale pour accélérer le développement du groupe aux Etats-Unis, tout en renforçant son catalogue de [...]

Summit Therapeutics plc : Grant of Share Options and Restricted Stock Units

19/07/2017 - 15:10

Summit Therapeutics plc ('Summit' or the 'Company') GRANT OF SHARE OPTIONS TO DIRECTORS, PDMRS AND EMPLOYEES AND GRANT OF RESTRICTED STOCK UNITS TO NON-EXECUTIVE DIRECTORS Oxford, UK, 19 July 2017 - Summit Therapeutics [...]

Medibio building credentials to "scale" via appointment of healthcare & telehealth icon to Board of Directors

19/07/2017 - 15:00

SYDNEY, Australia and MINNEAPOLIS, July 19, 2017 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX:MEB) (OTCQB:MDBIF), a digital health company that has developed an objective testing system to assist in [...]

ProMIS Neurosciences Presents at AAIC 2017 Data from Alzheimer's Disease Program

19/07/2017 - 13:30

Company Focused on Development of Antibodies that Selectively Target Toxic, Prion-Like Forms of Amyloid beta ProMIS Issues White Paper from AAIC Presentations Outlining Role of Toxic Misfolded Forms of Amyloid beta and [...]

Orion Group Half-Year Financial Report January-June 2017

19/07/2017 - 12:15

ORION CORPORATION HALF-YEAR FINANCIAL REPORT JANUARY-JUNE 2017 19 JULY 2017 AT 13.15 EEST Orion Group Half-Year Financial Report January-June 2017 Orion's net sales in January-June 2017 totalled EUR 552 million (EUR 535 [...]

Orion Corporation's financial reporting and Annual General Meeting in 2018

19/07/2017 - 10:00

ORION CORPORATION STOCK EXCHANGE RELEASE 19 JULY 2017 at 11.00 A.M. EEST Orion Corporation's financial reporting and Annual General Meeting in 2018 Orion Corporation will publish its Financial Statement Release 2017 on [...]

RECORDATI: THE EUROPEAN COMMISSION APPROVES REAGILA® (CARIPRAZINE) FOR THE TREATMENT OF SCHIZOPHRENIA

19/07/2017 - 09:08

Milan, 19 July 2017 - Recordati announces that Gedeon Richter Plc. was granted marketing authorization from the European Commission for Reagila® (cariprazine), a novel antipsychotic for the treatment of schizophrenia in [...]

MPI: OV to evaluate the potential of in-licensing a small molecule compound for development in cancer from a major Pharmaceutical company

19/07/2017 - 09:00

Hoersholm, Denmark, July 19, 2017 - Oncology Venture AB (OV:ST) and Novartis Pharma AG (Basel, Switzerland) have entered into an agreement providing Oncology Venture with an option right to execute an exclusive license [...]

NEOVACS obtient une nouvelle « Investigational New Drug (IND) » de la FDA dans la dermatomyosite aux Etats-Unis

19/07/2017 - 07:30

COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE Néovacs annonce avoir obtenu une nouvelle « Investigational New Drug ( IND ) » de la FDA pour élargir son programme de développement clinique avec l' [...]

Neovacs Announces FDA Acceptance of a New IND to Expand in U.S. IFNalpha Kinoid Clinical Development Program in Dermatomyositis

19/07/2017 - 07:30

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE Neovacs Announces FDA Acceptance of a New IND to Expand in U.S. IFNalpha Kinoid Clinical Development Program in Dermatomyositis This is the second clinical trial approved by [...]